Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.61 |
| ▸ | NNMT | P40261 | 2/20 | 0.60 |
| ▸ | GABRP | O00591 | 1/20 | 0.60 |
| ▸ | GABRD | O14764 | 1/20 | 0.60 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.60 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.60 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.60 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.60 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.60 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.60 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.60 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.60 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.60 |
| ▸ | GABRE | P78334 | 1/20 | 0.60 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.60 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.60 |
| ▸ | GABRG3 | Q99928 | 1/20 | 0.60 |
| ▸ | GABRQ | Q9UN88 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29826707 | 1.00 | MAPK1 (0.65) | MAPK1KDM4EL3MBTL1NNMTGABRP | |
| Hydrochloric Acid SCHEMBL2177614 | 0.98 | MAPK1 (0.62) | MAPK1KDM4EL3MBTL1NNMTGABRP | |
| Tetrahydrofuran SCHEMBL28037003 | 0.87 | MAPK1 (0.51) | MAPK1KDM4EL3MBTL1NNMTGABRP | |
| SCHEMBL7362601 | 0.87 | MAPK1 (0.51) | MAPK1KDM4EL3MBTL1NNMTGABRP | |
| SCHEMBL5543060 | 0.86 | MKNK1 (0.65) | MAPK1KDM4EL3MBTL1NNMTGABRP | |
| SCHEMBL2734773 | 0.83 | CDK8 (0.53) | MAPK1KDM4ENNMTGABRPGABRD | |
| SCHEMBL2643803 | 0.81 | NNMT (0.56) | MAPK1KDM4EL3MBTL1NNMTGABRP | |
| 6-Aminonicotinamide SCHEMBL25343859 | 0.81 | NNMT (0.85) | KDM4EL3MBTL1NNMTGABRPGABRD | |
| SCHEMBL13914474 | 0.81 | NNMT (0.66) | MAPK1KDM4EL3MBTL1NNMTGABRP | |
| SCHEMBL30474684 | 0.81 | MAPK1 (0.65) | MAPK1KDM4EL3MBTL1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1808 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114998621-B | SERS quantitative analysis method based on coffee ring concentration effect and image processing technology | 嘉兴学院 | 2024-04-16 | — | — | CN | claimed |
| CN-114998621-A | SERS quantitative analysis method based on coffee ring concentration effect and image processing technology | 嘉兴学院 | 2022-09-02 | — | — | CN | claimed |
| CN-113816956-A | Synthesis method of pexidaltinib | 湖北工业大学 | 2021-12-21 | — | — | CN | claimed |
| CN-113429342-A | Synthesis method of pexidaltinib intermediate | 武汉格迪泰健康科技有限公司 | 2021-09-24 | — | — | CN | claimed |
| CN-110330488-A | A kind of piroxicam haptens and its preparation method and application | 深圳市易瑞生物技术股份有限公司 | 2019-10-15 | — | — | CN | claimed |
| US-8524774-B1 | Topical two step polytherapy for treatment of psoriasis and other skin disorders | CYMBIOTICS, INC. (US) | 2013-09-03 | — | — | US | claimed |
| US-4316902-A | Therapeutic compositions and vehicles for topical pharmaceuticals | YU RUEY J | 1982-02-23 | — | — | US | claimed |
| US-4252796-A | ALUMINUM COMPOUNDS, ANTIINFLAMMATORY AGENTS | YU RUEY J | 1981-02-24 | — | — | US | claimed |
| US-20260146042-A1 | PYRROLOPYRIMIDINE COMPOUNDS AND THEIR USES | NOVARTIS AG (CH) | 2026-05-28 | — | — | US | disclosed |
| US-12630528-B2 | Amino aryl derivative useful as diacylglycerol acyltransferase 2 inhibitor and use thereof | LG CHEM, LTD. (KR) | 2026-05-19 | — | — | US | disclosed |
| CN-122036587-A | Zalutst compound and application thereof in inhibiting MLL1-WDR5 interaction | 暨南大学 | 2026-05-15 | — | — | CN | disclosed |
| US-20260125400-A1 | TYK2 DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS INC (US) | 2026-05-07 | — | — | US | disclosed |
| US-12600729-B2 | New-type benzazepine fused ring derivative | SHANGHAI JEYOU PHARMACEUTICAL CO., LTD. (CN) | 2026-04-14 | — | — | US | disclosed |
| EP-4719385-A2 | 1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINES AS ANTI-INFECTIOUS AGENTS | University of Vermont and State Agricultural College (US) | 2026-04-08 | — | — | EP | disclosed |
| US-4310526-A | Substituted 6,7-methylene pyrido[1,2-a]pyrimidines useful as anti-allergic and anti-ulcer agents | FARMITALIA CARLO ERBA S.P.A. (IT) | 1982-01-12 | — | — | US | disclosed |
| US-4284630-A | Stabilized water-in-oil emulsions | YU RUEY J | 1981-08-18 | — | — | US | disclosed |
| US-4252796-A | ALUMINUM COMPOUNDS, ANTIINFLAMMATORY AGENTS | YU RUEY J | 1981-02-24 | — | — | US | disclosed |
| US-4141977-A | Treatment of psoriasis with 6-substituted nicotinamides, 2-substituted pyrazinamides and closely related compounds | YU RUEY J | 1979-02-27 | — | — | US | disclosed |
| US-4067975-A | Treatment of psoriasis with 6-aminonicotinamide and thionicotinamide | YU RUEY J | 1978-01-10 | — | — | US | disclosed |
| US-4067975-A | Treatment of psoriasis with 6-aminonicotinamide and thionicotinamide | YU RUEY J | 1978-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125400-A1 | TYK2 DEGRADERS AND USES THEREOF | TYK2, CSNK2A1, CSNK2A2 | MAPK1 1825/4885KDM4E 810/4885L3MBTL1 2459/4885 |
| US-20260146042-A1 | PYRROLOPYRIMIDINE COMPOUNDS AND THEIR USES | CDK9, CDK6, CDK7 | MAPK1 118/4885KDM4E 634/4885L3MBTL1 1901/4885 |
| US-12630528-B2 | Amino aryl derivative useful as diacylglycerol acyltransferase 2 inhibitor and use thereof | DGAT2, DGAT1, SOAT2 | MAPK1 1783/4885KDM4E 2839/4885L3MBTL1 1846/4885 |
| US-12600729-B2 | New-type benzazepine fused ring derivative | AVPR1B, AVPR2, AVPR1A | MAPK1 1588/4885KDM4E 3354/4885L3MBTL1 1699/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.